CRP

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BezisterimHE-3286; NE-3107Phase 3 ClinicalHarbor Therapeutics, Biovie IncDiabetes Mellitus, Type 2; Brain Injuries, Traumatic; Insulin Resistance; Arthritis, Rheumatoid; Post-Acute COVID-19 Syndrome; Alzheimer Disease; Colitis, Ulcerative; Parkinson Disease
Details
PN-235JNJ-77242113; PN-235; JNJ-2113; PN-21235; JNJ-77242113-AACPhase 3 ClinicalProtagonist Therapeutics IncPsoriasis; Colitis, Ulcerative; Plaque psoriasis
Details
PN-232PN-232; JNJ75105186Phase 1 ClinicalProtagonist Therapeutics Inc
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Ustekinumab biosimilar (Samsung Bioepis)SB-17; SB17ApprovedSamsung Bioepis Co LtdPyzchivaEUCrohn Disease; Colitis, UlcerativeSamsung Bioepis Nl Bv2024-04-19Gastrointestinal Diseases; Skin Diseases; Psoriasis; Arthritis, Psoriatic; Rheumatic Diseases; Colitis, Ulcerative; Inflammation; Crohn Disease; Plaque psoriasis
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8